These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 10424042)

  • 1. [An analysis of the correlations in the indices of the hemopoietic, biochemical and immunological characteristics in patients with acute myelo- and lymphoblastic leukemias].
    Pesotskaia LA
    Lik Sprava; 1999 Mar; (2):53-6. PubMed ID: 10424042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Levels of extracellular DNA and polyamines as criteria of resistance to chemotherapy in patients with acute leukemia].
    Kovtunova ME; Pan'kov VN; Vorozhtsova SI; Riabova TI; Tselousova OM
    Vopr Med Khim; 1990; 36(5):83-5. PubMed ID: 2251804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypercoagulable state and hemorrhage in acute leukemias.
    He LZ; Lu LH
    Chin Med J (Engl); 1988 Jun; 101(6):448-53. PubMed ID: 3146479
    [No Abstract]   [Full Text] [Related]  

  • 4. Levels of circulating endothelial adhesion molecules (sE-selectin and sVCAM-1) in adult patients with acute leukemia.
    Südhoff T; Wehmeier A; Kliche KO; Aul C; Schlömer P; Bauser U; Schneider W
    Leukemia; 1996 Apr; 10(4):682-6. PubMed ID: 8618447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristics of the blood serum proteinogram in patients with acute leukemia].
    Pesotskaia LA
    Vrach Delo; 1989 Jun; (6):66-70. PubMed ID: 2781768
    [No Abstract]   [Full Text] [Related]  

  • 6. Leptin in acute leukaemias: relationship to interleukin-6 and vascular endothelial growth factor.
    Hamed NA; Sharaki OA; Zeidan MM
    Egypt J Immunol; 2003; 10(1):57-66. PubMed ID: 15719623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The immunological indices of patients with chronic myeloleukemia at the blast crisis stage].
    Romanova AF; Fedorovskaia EA; Pesotskaia LA
    Vrach Delo; 1991 Apr; (4):65-7. PubMed ID: 2063572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on relationship between cellular immunity and TCM typing in patients with minimal residual leukemia].
    Zhang SS; Xu YG; Yang XH
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Jan; 24(1):36-40. PubMed ID: 14976887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experiences of immunologic phenotyping in acute leukemia].
    Brinch L; Evensen SA; Stavem P; Smeland EB
    Tidsskr Nor Laegeforen; 1989 Feb; 109(4):443-6. PubMed ID: 2919374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet function in acute leukemias.
    Naresh KN; Sivasankaran P; Veliath AJ
    J Assoc Physicians India; 1993 Jun; 41(6):377-8. PubMed ID: 8005978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The dynamic indices of the hemopoietic status in patients with acute lymphoblastic leukemia].
    Pesotskaia LA
    Lik Sprava; 1998; (1):101-3. PubMed ID: 9621629
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression of the multidrug resistance-associated protein (MRP) in acute and chronic leukemias.
    Burger H; Nooter K; Zaman GJ; Sonneveld P; van Wingerden KE; Oostrum RG; Stoter G
    Leukemia; 1994 Jun; 8(6):990-7. PubMed ID: 7911548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intracellular retention of cytarabine-triphosphate (Ara-CTP) in blasts of children with acute lymphoblastic leukemia. Correlation with clinical course parameters].
    Schiller M; Hohenlöchter B; Schulze-Westhoff P; Zimmermann M; Ritter J; Jürgens H; Boos J
    Klin Padiatr; 1996; 208(4):151-9. PubMed ID: 8926681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The efficacy of active specific immunotherapy using modified neoplastic cells in the combined modality treatment of hemoblastoses].
    Zverkova AS; Bratus' GG; Darchuk GF; Komissarenko VG; Koval' AI; Tretiak NN; Gashchuk AP; Vakul'chuk AM; Ruzhinskaia EE; Dzhevadova IV
    Lik Sprava; 1998 Dec; (8):88-94. PubMed ID: 10204358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematological recovery after autologous bone marrow transplantation in acute leukemia: predictive factors.
    Canals C; Marti JM; Martinez E; Sierra J; Punti C; Granena A; Domingo A; Cubells J; Brunet S; Badell I
    J Hematother; 1993; 2(1):75-85. PubMed ID: 7921968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The morphological and immunological classification of acute leukemias].
    Jansson SE
    Duodecim; 1989; 105(11):973-86. PubMed ID: 2666098
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute leukemia presenting as acute hepatitis without liver failure.
    Rivet C; Leverger G; Jacquemin E; Bernard O
    J Pediatr Gastroenterol Nutr; 2014 Nov; 59(5):640-1. PubMed ID: 25003374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal residual disease testing in acute leukemia by flow cytometry immunophenotyping: prognostic significance.
    Ruiz-Argüelles GJ; Fernández-Lara D; Estrada-Gómez R; Manzano C; Ruiz-Delgado GJ; Pérez-Romano B; Ruiz-Argüelles A
    Lab Hematol; 2007; 13(1):22-6. PubMed ID: 17353179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of lymphocytotoxic and platelet reactive antibodies: a prospective study in patients with acute leukaemia.
    Pamphilon DH; Farrell DH; Donaldson C; Raymond PA; Brady CA; Bradley BA
    Vox Sang; 1989; 57(3):177-81. PubMed ID: 2617951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnesium and iron contents of leukemic lymphocytes in acute leukemias and hemolytic anemia.
    Rzymowska J
    Biol Trace Elem Res; 1996; 53(1-3):235-9. PubMed ID: 8862752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.